Evidence map›Paper›PMID 42368251›Full record

ArticleOncology research2026

New Paradigm in Ocular Surface Squamous Neoplasia-Insights from a Case Report on the Use of Interferon in Treatment.

Ferdinando Cione, Maddalena De Bernardo, Mario Graziano, Palmiro Cornetta, Rossella Centola, Alessandro Caputo, Pio Zeppa, Amelia Filippelli

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ferdinando CioneDepartment of Medicine, Surgery and Dentistry, "Scuola Medica Salernitana", University of Salerno, Baronissi, Salerno, Italy.ORCID https://orcid.org/0000-0002-1031-6434
Maddalena De BernardoDepartment of Medicine, Surgery and Dentistry, "Scuola Medica Salernitana", University of Salerno, Baronissi, Salerno, Italy.
Mario GrazianoDepartment of Medicine, Surgery and Dentistry, "Scuola Medica Salernitana", University of Salerno, Baronissi, Salerno, Italy.
Palmiro CornettaPresidio Ospedaliero "Maria SS Addolorata", ASL Salerno, Eboli, Piazza Scuola Medica Salernitana, Eboli, Salerno, Italy.
Rossella CentolaDepartment of Pharmacy, University Hospital "San Giovanni di Dio e Ruggi D'Aragona", Via San Leonardo, Salerno, Italy.
Alessandro CaputoDepartment of Medicine, Surgery and Dentistry, "Scuola Medica Salernitana", University of Salerno, Baronissi, Salerno, Italy.
Pio ZeppaDepartment of Medicine, Surgery and Dentistry, "Scuola Medica Salernitana", University of Salerno, Baronissi, Salerno, Italy.
Amelia FilippelliDepartment of Medicine, Surgery and Dentistry, "Scuola Medica Salernitana", University of Salerno, Baronissi, Salerno, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsCarcinoma, Squamous CellConjunctival NeoplasmsEye NeoplasmsInterferon-alphaInterferon alpha-2AgedFemaleHumansNeoplasm Recurrence, LocalTreatment OutcomeAntineoplastic AgentsInterferon-alphaInterferon alpha-2Case reportconjunctivalinterferon-alphaocular surfacepapillomarecurrencetopical

Identifiers

PMID42368251
PMCPMC13294770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.